HRG and neoplasm: The plasma-protein histidine-rich glycoprotein (HRG), a cation- and heparin- binding plasma glycoprotein, controls the phenotypic switching of macrophages through enhancing cytokine production and phagocytotic activity in tumours, resulting in the vessel normalization and antitumor immune responses.